Literature DB >> 29618526

Opportunities and obstacles for deep learning in biology and medicine.

Travers Ching1, Daniel S Himmelstein2, Brett K Beaulieu-Jones3, Alexandr A Kalinin4, Brian T Do5, Gregory P Way2, Enrico Ferrero6, Paul-Michael Agapow7, Michael Zietz2, Michael M Hoffman8,9,10, Wei Xie11, Gail L Rosen12, Benjamin J Lengerich13, Johnny Israeli14, Jack Lanchantin15, Stephen Woloszynek12, Anne E Carpenter16, Avanti Shrikumar17, Jinbo Xu18, Evan M Cofer19,20, Christopher A Lavender21, Srinivas C Turaga22, Amr M Alexandari17, Zhiyong Lu23, David J Harris24, Dave DeCaprio25, Yanjun Qi15, Anshul Kundaje17,26, Yifan Peng23, Laura K Wiley27, Marwin H S Segler28, Simina M Boca29, S Joshua Swamidass30, Austin Huang31, Anthony Gitter32,33, Casey S Greene34.   

Abstract

Deep learning describes a class of machine learning algorithms that are capable of combining raw inputs into layers of intermediate features. These algorithms have recently shown impressive results across a variety of domains. Biology and medicine are data-rich disciplines, but the data are complex and often ill-understood. Hence, deep learning techniques may be particularly well suited to solve problems of these fields. We examine applications of deep learning to a variety of biomedical problems-patient classification, fundamental biological processes and treatment of patients-and discuss whether deep learning will be able to transform these tasks or if the biomedical sphere poses unique challenges. Following from an extensive literature review, we find that deep learning has yet to revolutionize biomedicine or definitively resolve any of the most pressing challenges in the field, but promising advances have been made on the prior state of the art. Even though improvements over previous baselines have been modest in general, the recent progress indicates that deep learning methods will provide valuable means for speeding up or aiding human investigation. Though progress has been made linking a specific neural network's prediction to input features, understanding how users should interpret these models to make testable hypotheses about the system under study remains an open challenge. Furthermore, the limited amount of labelled data for training presents problems in some domains, as do legal and privacy constraints on work with sensitive health records. Nonetheless, we foresee deep learning enabling changes at both bench and bedside with the potential to transform several areas of biology and medicine.
© 2018 The Authors.

Entities:  

Keywords:  deep learning; genomics; machine learning; precision medicine

Mesh:

Year:  2018        PMID: 29618526      PMCID: PMC5938574          DOI: 10.1098/rsif.2017.0387

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.293


  274 in total

Review 1.  DNA binding sites: representation and discovery.

Authors:  G D Stormo
Journal:  Bioinformatics       Date:  2000-01       Impact factor: 6.937

Review 2.  Computer vision for high content screening.

Authors:  Oren Z Kraus; Brendan J Frey
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-01-24       Impact factor: 8.250

3.  XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.

Authors:  Jed Zaretzki; Matthew Matlock; S Joshua Swamidass
Journal:  J Chem Inf Model       Date:  2013-11-23       Impact factor: 4.956

4.  Reproducibility of computational workflows is automated using continuous analysis.

Authors:  Brett K Beaulieu-Jones; Casey S Greene
Journal:  Nat Biotechnol       Date:  2017-03-13       Impact factor: 54.908

5.  Automated Melanoma Recognition in Dermoscopy Images via Very Deep Residual Networks.

Authors:  Lequan Yu; Hao Chen; Qi Dou; Jing Qin; Pheng-Ann Heng
Journal:  IEEE Trans Med Imaging       Date:  2016-12-21       Impact factor: 10.048

6.  Metagenomic microbial community profiling using unique clade-specific marker genes.

Authors:  Nicola Segata; Levi Waldron; Annalisa Ballarini; Vagheesh Narasimhan; Olivier Jousson; Curtis Huttenhower
Journal:  Nat Methods       Date:  2012-06-10       Impact factor: 28.547

Review 7.  Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research.

Authors:  Nicole Gray Weiskopf; Chunhua Weng
Journal:  J Am Med Inform Assoc       Date:  2012-06-25       Impact factor: 4.497

8.  Big Data: Astronomical or Genomical?

Authors:  Zachary D Stephens; Skylar Y Lee; Faraz Faghri; Roy H Campbell; Chengxiang Zhai; Miles J Efron; Ravishankar Iyer; Michael C Schatz; Saurabh Sinha; Gene E Robinson
Journal:  PLoS Biol       Date:  2015-07-07       Impact factor: 8.029

9.  DectICO: an alignment-free supervised metagenomic classification method based on feature extraction and dynamic selection.

Authors:  Xiao Ding; Fudong Cheng; Changchang Cao; Xiao Sun
Journal:  BMC Bioinformatics       Date:  2015-10-07       Impact factor: 3.169

10.  Modeling Reactivity to Biological Macromolecules with a Deep Multitask Network.

Authors:  Tyler B Hughes; Na Le Dang; Grover P Miller; S Joshua Swamidass
Journal:  ACS Cent Sci       Date:  2016-07-29       Impact factor: 14.553

View more
  328 in total

Review 1.  Machine learning, the kidney, and genotype-phenotype analysis.

Authors:  Rachel S G Sealfon; Laura H Mariani; Matthias Kretzler; Olga G Troyanskaya
Journal:  Kidney Int       Date:  2020-04-01       Impact factor: 10.612

2.  Open collaborative writing with Manubot.

Authors:  Daniel S Himmelstein; Vincent Rubinetti; David R Slochower; Dongbo Hu; Venkat S Malladi; Casey S Greene; Anthony Gitter
Journal:  PLoS Comput Biol       Date:  2019-06-24       Impact factor: 4.475

3.  deepDR: a network-based deep learning approach to in silico drug repositioning.

Authors:  Xiangxiang Zeng; Siyi Zhu; Xiangrong Liu; Yadi Zhou; Ruth Nussinov; Feixiong Cheng
Journal:  Bioinformatics       Date:  2019-12-15       Impact factor: 6.937

4.  A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL.

Authors:  Zijun Y Xu-Monette; Hongwei Zhang; Feng Zhu; Alexandar Tzankov; Govind Bhagat; Carlo Visco; Karen Dybkaer; April Chiu; Wayne Tam; Youli Zu; Eric D Hsi; Hua You; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Benjamin M Parsons; J Han van Krieken; Miguel A Piris; Jane N Winter; Fredrick B Hagemeister; Babak Shahbaba; Ivan De Dios; Hong Zhang; Yong Li; Bing Xu; Maher Albitar; Ken H Young
Journal:  Blood Adv       Date:  2020-07-28

5.  Technical and imaging factors influencing performance of deep learning systems for diabetic retinopathy.

Authors:  Michelle Y T Yip; Gilbert Lim; Zhan Wei Lim; Quang D Nguyen; Crystal C Y Chong; Marco Yu; Valentina Bellemo; Yuchen Xie; Xin Qi Lee; Haslina Hamzah; Jinyi Ho; Tien-En Tan; Charumathi Sabanayagam; Andrzej Grzybowski; Gavin S W Tan; Wynne Hsu; Mong Li Lee; Tien Yin Wong; Daniel S W Ting
Journal:  NPJ Digit Med       Date:  2020-03-23

6.  DeepCOMBI: explainable artificial intelligence for the analysis and discovery in genome-wide association studies.

Authors:  Bettina Mieth; Alexandre Rozier; Juan Antonio Rodriguez; Marina M C Höhne; Nico Görnitz; Klaus-Robert Müller
Journal:  NAR Genom Bioinform       Date:  2021-07-20

Review 7.  Developing Real-world Evidence-Ready Datasets: Time for Clinician Engagement.

Authors:  James M Snyder; Jacob A Pawloski; Laila M Poisson
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

8.  Prediction of regulatory motifs from human Chip-sequencing data using a deep learning framework.

Authors:  Jinyu Yang; Anjun Ma; Adam D Hoppe; Cankun Wang; Yang Li; Chi Zhang; Yan Wang; Bingqiang Liu; Qin Ma
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

Review 9.  How Machine Learning Will Transform Biomedicine.

Authors:  Jeremy Goecks; Vahid Jalili; Laura M Heiser; Joe W Gray
Journal:  Cell       Date:  2020-04-02       Impact factor: 41.582

10.  How to rekindle drug discovery process through integrative therapeutic targeting?

Authors:  Ashok Vaidya; Anuradha Roy; Rathnam Chaguturu
Journal:  Expert Opin Drug Discov       Date:  2018-08-27       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.